NCT05170061 - 24 Hour Ambulatory Cardiac Oxygen Consumption | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions

Hypertension

Interventions

DRUG

Nebivolol

Nebivolol 20 mg daily (1 week) followed by nebivolol 40 mg daily (3 weeks) followed by nebivolol 20 mg daily (1 week)

DRUG

Valsartan

Valsartan 160 mg daily (1 week) followed by valsartan 320 mg daily (3 weeks) followed by valsartan 160 mg daily (1 week).

DRUG

Nebivolol/valsartan combination

Valsartan/Nebivolol, 160/20 mg daily (1 week) followed by valsartan/nebivolol 320/40 mg daily (3 weeks) followed by valsartan/nebivolol 160/20 mg daily (1 week)

Trial Locations (1)

14215

Erie County Medical Center, Buffalo

All Listed Sponsors

lead

State University of New York at Buffalo

OTHER